Cholangitis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (Bot: Removing from Primary care)
 
(31 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{CMG}}
 
{{CMG}}; {{AE}} {{ADS}}, {{FH}}
{{Cholangitis}}
{{Cholangitis}}
==Overview==
==Overview==
Common risk factors in the development of cholangitis are [[gallstones]], [[sclerosing cholangitis]], and [[HIV]].
The common [[risk factors]] in the development of cholangitis are dilatation of [[Common bile duct|common bile duct,]] [[CBD]] stones, [[gallstones]], [[sclerosing cholangitis]], and [[HIV]].  
==Risk factors==
===Common risk factors===
Common [[risk factors]] in the development of cholangitis include:<ref name="pmid2294844">{{cite journal |vauthors=Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK, Wong J |title=Emergency surgery for severe acute cholangitis. The high-risk patients |journal=Ann. Surg. |volume=211 |issue=1 |pages=55–9 |year=1990 |pmid=2294844 |pmc=1357893 |doi= |url=}}</ref><ref name="pmid2930289">{{cite journal |vauthors=Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H |title=Acute cholangitis. Multivariate analysis of risk factors |journal=Ann. Surg. |volume=209 |issue=4 |pages=435–8 |year=1989 |pmid=2930289 |pmc=1493983 |doi= |url=}}</ref><ref name="CatalanoSahani2009">{{cite journal|last1=Catalano|first1=Onofrio A.|last2=Sahani|first2=Dushyant V.|last3=Forcione|first3=David G.|last4=Czermak|first4=Benedikt|last5=Liu|first5=Chang-Hsien|last6=Soricelli|first6=Andrea|last7=Arellano|first7=Ronald S.|last8=Muller|first8=Peter R.|last9=Hahn|first9=Peter F.|title=Biliary Infections: Spectrum of Imaging Findings and Management|journal=RadioGraphics|volume=29|issue=7|year=2009|pages=2059–2080|issn=0271-5333|doi=10.1148/rg.297095051}}</ref><ref name="YamamotoIshida2013">{{cite journal|last1=Yamamoto|first1=Ryuichi|last2=Ishida|first2=Shuko|last3=Osafune|first3=Yasuyo|last4=Takahashi|first4=Masatomo|last5=Harada|first5=Maiko|last6=Kato|first6=Shingo|last7=Nagoshi|first7=Sumiko|last8=Nishikawa|first8=Ko|last9=Yakabi|first9=Koji|title=Su1416 Risk Factors for Acute Cholangitis Caused by Common Bile Duct Stone: a Single-Center Study|journal=Gastrointestinal Endoscopy|volume=77|issue=5|year=2013|pages=AB316–AB317|issn=00165107|doi=10.1016/j.gie.2013.03.1069}}</ref>
*Surgery of the [[biliary tract]]<ref name="pmid7716962">{{cite journal| author=Cybulski Z, Solarski J, Majewski W| title=[Infection as a risk factor in biliary system surgery]. | journal=Wiad Lek | year= 1994 | volume= 47 | issue= 15-16 | pages= 619-24 | pmid=7716962 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7716962  }} </ref>
*Dilatation of [[common bile duct]] (CBD)
*Previous history of [[gallstones]]
*Large [[CBD]] stones
*A history of [[sclerosing cholangitis]]
*Advanced age (>70 years of age)
* Procedure like [[ERCP]]<ref name="pmid1406012">{{cite journal| author=Sauter G, Ruckdeschel G, Sauerbruch T| title=[Antibiotic prevention and therapy of infectious complications in ERCP]. | journal=Leber Magen Darm | year= 1992 | volume= 22 | issue= 5 | pages= 173-6 | pmid=1406012 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1406012  }} </ref>


==Risk Factors==
===Less common risk factors===
Less common [[risk factors]] in the development of cholangitis include:<ref name="pmid2294844" /><ref name="pmid2930289" /><ref name="CatalanoSahani2009" /><ref name="YamamotoIshida2013" />
*[[HIV]]
*[[Neurological|Neurologic]] disease
*Narrowing of the [[common bile duct]] due to cancer
*Traveling to countries where you might catch a worm or [[Parasites|parasite]] infection
*Presence of [[liver abscess]]
*[[Acute renal failure]]
*Periampullary [[Diverticular|diverticula]]


* Previous history of [[gallstones]]
The [[bile]] of healthy individuals is generally [[aseptic]].<ref name="pmid17252293">{{cite journal |vauthors=Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR |title=Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines |journal=J Hepatobiliary Pancreat Surg |volume=14 |issue=1 |pages=15–26 |year=2007 |pmid=17252293 |pmc=2784509 |doi=10.1007/s00534-006-1152-y |url=}}</ref>
* [[Sclerosing cholangitis]]
*[[Bile]] culture is positive for [[microorganisms]] in:
* [[HIV]]
**16% of patients undergoing a non-biliary operation  
* Narrowing of the [[common bile duct]]
**72% of acute cholangitis patients
* Traveling to countries where you might catch a worm or [[parasite infection]]
**44% of chronic cholangitis patients  
 
**50% of patients with [[biliary obstruction]]
 
*The [[bacteria]] in bile are identified in 90% of patients with [[choledocholithiasis]], accompanied by [[jaundice]].
*Advanced age (>70 years), neurologic disease, and [[periampullary diverticula are risk factors for development of cholangitis in patients with biliary stones
*Patients with incomplete obstruction of the [[bile duct]] present with a higher positive [[bile]] culture rate than those with complete obstruction of the [[bile duct]].<ref name="pmid17252293">{{cite journal |vauthors=Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR |title=Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines |journal=J Hepatobiliary Pancreat Surg |volume=14 |issue=1 |pages=15–26 |year=2007 |pmid=17252293 |pmc=2784509 |doi=10.1007/s00534-006-1152-y |url=}}</ref>
http://pubs.rsna.org/doi/full/10.1148/rg.297095051
 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784509/
The bile of healthy subjects is generally aseptic. However, bile culture is positive for microorganisms in 16% of patients undergoing a non-biliary operation, in 72% of acute cholangitis patients, in 44% of chronic cholangitis patients, and in 50% of those with biliary obstruction (level 4).12 Bacteria in bile are identified in 90% of patients with choledocholithiasis accompanied by jaundice (level 4).13 Patients with incomplete obstruction of the bile duct present a higher positive bile culture rate than those with complete obstruction of the bile duct. Risk factors for bactobilia include various factors, as described above


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
 
[[Category:Up-To-Date]]
{{WikiDoc Help Menu}}
[[Category:Infectious disease]]
{{WikiDoc Sources}}
[[Category:Surgery]]

Latest revision as of 20:55, 29 July 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2], Farwa Haideri [3]

Cholangitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cholangitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Cholangitis risk factors On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cholangitis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cholangitis risk factors

CDC on Cholangitis risk factors

Cholangitis risk factors in the news

Blogs on Cholangitis risk factors

Directions to Hospitals Treating Cholangitis

Risk calculators and risk factors for Cholangitis risk factors

Overview

The common risk factors in the development of cholangitis are dilatation of common bile duct, CBD stones, gallstones, sclerosing cholangitis, and HIV.

Risk factors

Common risk factors

Common risk factors in the development of cholangitis include:[1][2][3][4]

Less common risk factors

Less common risk factors in the development of cholangitis include:[1][2][3][4]

The bile of healthy individuals is generally aseptic.[7]

References

  1. 1.0 1.1 Lai EC, Tam PC, Paterson IA, Ng MM, Fan ST, Choi TK, Wong J (1990). "Emergency surgery for severe acute cholangitis. The high-risk patients". Ann. Surg. 211 (1): 55–9. PMC 1357893. PMID 2294844.
  2. 2.0 2.1 Gigot JF, Leese T, Dereme T, Coutinho J, Castaing D, Bismuth H (1989). "Acute cholangitis. Multivariate analysis of risk factors". Ann. Surg. 209 (4): 435–8. PMC 1493983. PMID 2930289.
  3. 3.0 3.1 Catalano, Onofrio A.; Sahani, Dushyant V.; Forcione, David G.; Czermak, Benedikt; Liu, Chang-Hsien; Soricelli, Andrea; Arellano, Ronald S.; Muller, Peter R.; Hahn, Peter F. (2009). "Biliary Infections: Spectrum of Imaging Findings and Management". RadioGraphics. 29 (7): 2059–2080. doi:10.1148/rg.297095051. ISSN 0271-5333.
  4. 4.0 4.1 Yamamoto, Ryuichi; Ishida, Shuko; Osafune, Yasuyo; Takahashi, Masatomo; Harada, Maiko; Kato, Shingo; Nagoshi, Sumiko; Nishikawa, Ko; Yakabi, Koji (2013). "Su1416 Risk Factors for Acute Cholangitis Caused by Common Bile Duct Stone: a Single-Center Study". Gastrointestinal Endoscopy. 77 (5): AB316–AB317. doi:10.1016/j.gie.2013.03.1069. ISSN 0016-5107.
  5. Cybulski Z, Solarski J, Majewski W (1994). "[Infection as a risk factor in biliary system surgery]". Wiad Lek. 47 (15–16): 619–24. PMID 7716962.
  6. Sauter G, Ruckdeschel G, Sauerbruch T (1992). "[Antibiotic prevention and therapy of infectious complications in ERCP]". Leber Magen Darm. 22 (5): 173–6. PMID 1406012.
  7. 7.0 7.1 Kimura Y, Takada T, Kawarada Y, Nimura Y, Hirata K, Sekimoto M, Yoshida M, Mayumi T, Wada K, Miura F, Yasuda H, Yamashita Y, Nagino M, Hirota M, Tanaka A, Tsuyuguchi T, Strasberg SM, Gadacz TR (2007). "Definitions, pathophysiology, and epidemiology of acute cholangitis and cholecystitis: Tokyo Guidelines". J Hepatobiliary Pancreat Surg. 14 (1): 15–26. doi:10.1007/s00534-006-1152-y. PMC 2784509. PMID 17252293.


Template:WikiDoc Sources